A critical view on the war against prediabetes.

Science reporter Charles Piller questions the pharmaceutical industry incentives in the fight against prediabetes. “A third of Americans are considered prediabetic—but many may be better off without treatment.” My take: I think he makes a good point about incentives but somehow misses the fact that people don’t just wake up one day with full blown type 2 diabetes. ~ learn more